Eternity Insights has published a new study on Global Synthetic Biology Market focusing on key segments and regions. This in-depth research report highlights the market and competitive intelligence across the key segments of the market. The report also considers the impact of COVID-19 on the global Synthetic Biology Market.
The report considers 2019-2022 as historic period, 2023 as base year, and 2024-2034 as forecast period. The report includes quantitative analysis of the market supported by the market drivers, challenges, and trends to accurately map the market scenario and competition. Moreover, key insights related to market having direct impact on the market will also be covered.
Synthetic Biology Market report is based on robust research methodology designed using blend of research ap-proaches developed using secondary/desk research and validated through primary research and expert insights. Eternity Insights also uses paid databases such as FACIVA, Hoovers, and other bench-marking and forecasting tools to provide accurate statistical analysis of supply and demand trends.
To learn more about this report
To learn more about this report
Geographically, the market is categorized in to five regions as North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. North America region dominates the global Synthetic Biology market in terms of demand generation. The Synthetic Biology market in Asia Pacific region is expected to grow at significantly high growth rate. The regional market is further sub-segmented and analyzed at granular level across key countries. The report will include market size and forecast for Synthetic Biology market for below listed coun-tries across each region.
North America (U.S. and Canada), Europe (Germany, France, Italy, UK, Spain, and Rest of Europe), Asia Pacific (China, India, Japan, Australia, and Rest of Asia Pacific region); Latin America (Brazil, Mexico, and rest of the Latin America); Middle East and Africa (GCC, South Africa, and Rest of the Middle East and Africa).
To learn more about this report
The global Synthetic Biology market analysis report covers detailed analysis of competitive scenario across globe. The report includes profiles of leading players covering below details
Report Attributes | Details |
The market size value in 2023 | USD XX.XX Million |
CAGR (2024 - 2034) | XX.XX % |
The Revenue forecast in 2034 | USD XX.XX Million |
Base year for estimation | 2023 |
Historical data | 2019-2022 |
Forecast period | 2024-2034 |
Quantitative units |
|
Report Coverage | Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
Segments Covered | By Tool Outlook, Application Outlook, Regional Outlook |
By Tool Outlook | Oligonucleotides and Synthetic DNA, Enzymes, Cloning Technologies Kits, Synthetic Cells, Chassis Organisms, Xeno-nucleic Acids |
By Application Outlook | Medical Application, Artificial Tissue and Tissue Regeneration, Industrial Applications, Food & Agriculture, Environmental Applications |
Regional scope | North America, Europe, Asia Pacific, Latin America, Middle East & Africa |
Country scope | U.S., Canada, U.K., Germany, France, BENELUX, China, India, Japan, South Korea, Brazil, Saudi Arabia, UAE, Turkey |
Key companies profiled | Thermo Fisher Scientific, Merck KGaA, Agilent Technologies, Inc., Novozymes A/S, Ginkgo Bioworks, Amyris, Precigen, GenScript Biotech Corporation, Twist Bioscience, Synthetic Genomics, Codexis, Synthego |
Customization Available | Yes, the report can be tailored to meet your specific requirements. |
Table of Contents
1 Report Overview
1.1 Definition and Specification
1.2 Report Overview
1.2.1 Manufacturers Overview
1.2.2 Regions Overview
1.2.3 Type Overview
1.2.4 Application Overview
1.3 Industrial Chain
1.3.1 Synthetic Biology Overall Industrial Chain
1.3.2 Upstream
1.3.3 Downstream
1.4 Industry Situation
1.4.1 Industrial Policy
1.4.2 Product Preference
1.4.3 Economic/Political Environment
1.5 SWOT Analysis
2 Market Assessment by Type
2.1 Synthetic DNA Sales (K Units), Revenue (M USD) and Growth Rate 2017-2020
2.2 Synthetic Oligos Sales (K Units), Revenue (M USD) and Growth Rate 2017-2020
2.3 Synthetic Genes Sales (K Units), Revenue (M USD) and Growth Rate 2017-2020
2.4 Software Tools Sales (K Units), Revenue (M USD) and Growth Rate 2017-2020
2.5 Chassis Organisms Sales (K Units), Revenue (M USD) and Growth Rate 2017-2020
2.6 Synthetic Clones Sales (K Units), Revenue (M USD) and Growth Rate 2017-2020
2.7 Synthetic Cells Sales (K Units), Revenue (M USD) and Growth Rate 2017-2020
3 Asia Pacific Synthetic Biology Market Assessment by Type
3.1 Asia Pacific Market Performance (Sales, Revenue)
3.2 Key Players in Asia Pacific
4 North America Synthetic Biology Market Assessment by Type
4.1 North America Market Performance (Sales, Revenue)
4.2 Key Players in North America
5 Europe Synthetic Biology Market Assessment by Type
4.1 Europe Market Performance (Sales, Revenue)
4.2 Key Players in Europe
6 South America Synthetic Biology Market Assessment by Type
4.1 South America Market Performance (Sales, Revenue)
4.2 Key Players in South America
7 Middle Easr and Africa Synthetic Biology Market Assessment by Type
4.1 Middle Easr and Africa Market Performance (Sales, Revenue)
4.2 Key Players in Middle Easr and Africa
8 World Synthetic Biology Market Assessment by Type
8.1 Asia Pacific Synthetic Biology Market Assessment by Application (Consumption and Market Share)
8.2 North America Synthetic Biology Market Assessment by Application (Consumption and Market Share)
8.3 Europe Synthetic Biology Market Assessment by Application (Consumption and Market Share)
8.4 South America Synthetic Biology Market Assessment by Application (Consumption and Market Share)
8.5 Middle East and Africa Synthetic Biology Market Assessment by Application (Consumption and Market Share)
9 Company Profiles/Analysis
9.1 ThermoFisher Scientific
9.1.1 ThermoFisher Scientific Profiles
9.1.2 ThermoFisher Scientific Product Portfolio
9.1.3 ThermoFisher Scientific Synthetic Biology Business Performance
9.1.4 ThermoFisher Scientific Synthetic Biology Business Development and Market Status
9.2 Merck KGaA
9.2.1 Merck KGaA Profiles
9.2.2 Merck KGaA Product Portfolio
9.2.3 Merck KGaA Synthetic Biology Business Performance
9.2.4 Merck KGaA Synthetic Biology Business Development and Market Status
9.3 Novozymes
9.3.1 Novozymes Profiles
9.3.2 Novozymes Product Portfolio
9.3.3 Novozymes Synthetic Biology Business Performance
9.3.4 Novozymes Synthetic Biology Business Development and Market Status
9.4 Agilent Technologies
9.4.1 Agilent Technologies Profiles
9.4.2 Agilent Technologies Product Portfolio
9.4.3 Agilent Technologies Synthetic Biology Business Performance
9.4.4 Agilent Technologies Synthetic Biology Business Development and Market Status
9.5 Amyris
9.5.1 Amyris Profiles
9.5.2 Amyris Product Portfolio
9.5.3 Amyris Synthetic Biology Business Performance
9.5.4 Amyris Synthetic Biology Business Development and Market Status
9.6 GenScript
9.6.1 GenScript Profiles
9.6.2 GenScript Product Portfolio
9.6.3 GenScript Synthetic Biology Business Performance
9.6.4 GenScript Synthetic Biology Business Development and Market Status
9.7 Integrated DNA Technologies
9.7.1 Integrated DNA Technologies Profiles
9.7.2 Integrated DNA Technologies Product Portfolio
9.7.3 Integrated DNA Technologies Synthetic Biology Business Performance
9.7.4 Integrated DNA Technologies Synthetic Biology Business Development and Market Status
9.8 Twist Bioscience
9.8.1 Twist Bioscience Profiles
9.8.2 Twist Bioscience Product Portfolio
9.8.3 Twist Bioscience Synthetic Biology Business Performance
9.8.4 Twist Bioscience Synthetic Biology Business Development and Market Status
9.9 New England Biolabs
9.9.1 New England Biolabs Profiles
9.9.2 New England Biolabs Product Portfolio
9.9.3 New England Biolabs Synthetic Biology Business Performance
9.9.4 New England Biolabs Synthetic Biology Business Development and Market Status
9.10 Synthetic Genomics
9.10.1 Synthetic Genomics Profiles
9.10.2 Synthetic Genomics Product Portfolio
9.10.3 Synthetic Genomics Synthetic Biology Business Performance
9.10.4 Synthetic Genomics Synthetic Biology Business Development and Market Status
10 World Synthetic Biology Market Assessment by Players
10.1 Global Synthetic Biology Sales (K Units) and Market Share by Players 2017-2020
10.2 Global Synthetic Biology Revenue (M USD) and Market Share by Players 2017-2020
10.3 Global Synthetic Biology Price (USD/Unit) of Players 2017-2020
10.4 Global Synthetic Biology Gross Margin of Players 2017-2020
10.5 Market Concentration
11 Regional Market Performance by Segment of Players
11.1 North America
11.1.1 North America Synthetic Biology Sales Assessment of Players 2017-2020
11.1.2 North America Synthetic Biology Revenue Assessment of Players 2017-2020
11.1.3 North America Synthetic Biology Price Assessment of Players 2017-2020
11.1.4 North America Synthetic Biology Gross Margin Assessment of Players 2017-2020
11.1.5 Market Concentration
11.2 Europe
11.2.1 Europe Synthetic Biology Sales Assessment of Players 2017-2020
11.2.2 Europe Synthetic Biology Revenue Assessment of Players of Manufacturers 2017-2020
11.2.3 Europe Synthetic Biology Price Assessment of Players 2017-2020
11.2.4 Europe Synthetic Biology Gross Margin Assessment of Players 2017-2020
11.2.5 Market Concentration
11.3 Asia-Pacific Market Performance for Manufacturers
11.3.1 Asia-Pacific Synthetic Biology Sales Assessment of Players 2017-2020
11.3.2 Asia-Pacific Synthetic Biology Revenue Assessment of Players 2017-2020
11.3.3 Asia-Pacific Synthetic Biology Price Assessment of Players 2017-2020
11.3.4 Asia-Pacific Synthetic Biology Gross Margin Assessment of Players 2017-2020
11.3.5 Market Concentration
11.4 South America Market Performance for Players
11.4.1 South America Synthetic Biology Sales Assessment of Players 2017-2020
11.4.2 South America Synthetic Biology Revenue Assessment of Players 2017-2020
11.4.3 South America Synthetic Biology Price Assessment of Players 2017-2020
11.4.4 South America Synthetic Biology Gross Margin Assessment of Players 2017-2020
11.4.5 Market Concentration
11.5 Middle East and Africa Market Performance for Players
11.5.1 Middle East and Africa Synthetic Biology Sales Assessment of Players 2017-2020
11.5.2 Middle East and Africa Synthetic Biology Revenue Assessment of Players 2017-2020
11.5.3 Middle East and Africa Synthetic Biology Price Assessment of Players 2017-2020
11.5.4 Middle East and Africa Synthetic Biology Gross Margin Assessment of Players 2017-2020
11.5.5 Market Concentration
12 Regional Market Performance by Segment of Countries
12.1 Asia Pacific
12.1.1 Asia Pacific Synthetic Biology Sales by Countries/Regions 2017-2020
12.1.2 Asia Pacific Synthetic Biology Revenue by Countries/Regions 2017-2020
12.1.3 Asia Pacific Synthetic Biology Average Price by Countries/Regions 2017-2020
12.2 North America
12.2.1 North America Synthetic Biology Sales by Countries/Regions 2017-2020
12.2.2 North America Synthetic Biology Revenue by Countries/Regions 2017-2020
12.2.3 North America Synthetic Biology Average Price by Countries/Regions 2017-2020
12.3 Europe
12.3.1 Europe Synthetic Biology Sales by Countries/Regions 2017-2020
12.3.2 Europe Synthetic Biology Revenue by Countries/Regions 2017-2020
12.3.3 Europe Synthetic Biology Average Price by Countries/Regions 2017-2020
12.4 South America
12.4.1 South America Synthetic Biology Sales by Countries/Regions 2017-2020
12.4.2 South America Synthetic Biology Revenue by Countries/Regions 2017-2020
12.4.3 South America Synthetic Biology Average Price by Countries/Regions 2017-2020
12.5 Middle East and Africa
12.5.1 Middle East and Africa Synthetic Biology Sales by Countries/Regions 2017-2020
12.5.2 Middle East and Africa Synthetic Biology Revenue by Countries/Regions 2017-2020
12.5.3 Middle East and Africa Synthetic Biology Average Price by Countries/Regions 2017-2020
13 Technology and Opportunity
13.1 Technology
13.2 Market Opportunity
14 World Synthetic Biology Sales & Revenue Forecast 2021-2027
14.1 World Synthetic Biology Sales and Revenue Forecast by Regions 2021-2027
14.1.1 World Synthetic BiologySales and Market Share by Regions
14.1.2 World Synthetic BiologyRevenue and Market Share by Regions
15 Asia Synthetic Biology Market Forecast 2021-2027
15.1 Sales and Revenue (M USD) Forecast by Type, 2021-2027
15.1.1 Synthetic DNA
15.1.2 Synthetic Oligos
15.1.3 Synthetic Genes
15.1.4 Software Tools
15.1.5 Chassis Organisms
15.1.6 Synthetic Clones
15.1.7 Synthetic Cells
15.2 Consumption Forecast by Application, 2021-2027
16 North America Synthetic Biology Market Forecast 2021-2027
16.1 Sales and Revenue (M USD) Forecast by Type, 2021-2027
16.1.1 Synthetic DNA
16.1.2 Synthetic Oligos
16.1.3 Synthetic Genes
16.1.4 Software Tools
16.1.5 Chassis Organisms
16.1.6 Synthetic Clones
16.1.7 Synthetic Cells
16.2 Consumption Forecast by Application, 2021-2027
17 Europe Synthetic Biology Market Forecast 2021-2027
17.1 Sales and Revenue (M USD) Forecast by Type, 2021-2027
17.1.1 Synthetic DNA
17.1.2 Synthetic Oligos
17.1.3 Synthetic Genes
17.1.4 Software Tools
17.1.5 Chassis Organisms
17.1.6 Synthetic Clones
17.1.7 Synthetic Cells
17.2 Consumption Forecast by Application, 2021-2027
18 South America Synthetic Biology Market Forecast 2021-2027
18.1 Sales and Revenue (M USD) Forecast by Type, 2021-2027
18.1.1 Synthetic DNA
18.1.2 Synthetic Oligos
18.1.3 Synthetic Genes
18.1.4 Software Tools
18.1.5 Chassis Organisms
18.1.6 Synthetic Clones
18.1.7 Synthetic Cells
18.2 Consumption Forecast by Application, 2021-2027
19 Middle East and Africa Synthetic Biology Market Forecast 2021-2027
19.1 Sales and Revenue (M USD) Forecast by Type, 2021-2027
19.1.1 Synthetic DNA
19.1.2 Synthetic Oligos
19.1.3 Synthetic Genes
19.1.4 Software Tools
19.1.5 Chassis Organisms
19.1.6 Synthetic Clones
19.1.7 Synthetic Cells
19.2 Consumption Forecast by Application, 2021-2027
20 Price (USD/Unit) and Gross Profit Forecast
20.1 Global Synthetic Biology Price (USD/Unit) Trend 2021-2027
20.2 Global Synthetic Biology Gross Profit Trend 2021-2027
21 Conclusion
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers
A faster and efficient way to cater to the needs with continuous iteration
Focus on Data Accuracy & Reliability
75+ Clients in Fortune 500
All your transactions are secured end-to-end, ensuring a satisfactory purchase
Ensure the best and affordable pricing